0
Chronic Disease Flexible Coverage Act
3/8/2025, 6:28 AM
Summary of Bill HR 919
The bill seeks to provide clarity and consistency in the treatment of preventive care services and items for individuals with chronic conditions. By codifying the IRS guidance, the bill aims to ensure that individuals with chronic conditions can access necessary preventive care without having to meet their high deductible before receiving coverage.
Under the bill, services and items for chronic conditions that are considered preventive care would be eligible for coverage under HDHPs without requiring individuals to first meet their deductible. This would help individuals with chronic conditions better manage their health and potentially reduce long-term healthcare costs. Overall, the Preventive Care for Chronic Conditions Act aims to improve access to preventive care for individuals with chronic conditions, promote better health outcomes, and potentially lower healthcare costs in the long run.
Congressional Summary of HR 919
Chronic Disease Flexible Coverage Act
This bill provides statutory authority for guidance from the Internal Revenue Service (IRS) that expands the types of preventive care that may be offered under a high deductible health plan (HDHP) without requiring a deductible or with a deductible below the minimum threshold.
Under current law, to be considered health savings account-eligible, an HDHP must have a deductible above a certain minimum threshold amount, which is adjusted annually. However, an HDHP may cover certain types of preventive care without requiring a deductible or with a deductible below the minimum threshold.
The IRS issued guidance expanding the types of preventive care that may be covered by an HDHP without requiring a deductible or with a deductible below the minimum threshold to include
- angiotensin converting enzyme inhibitors for individuals with congestive heart failure, diabetes, or coronary artery disease;
- anti-resorptive therapy for individuals with osteoporosis or osteopenia;
- beta-blockers for individuals with congestive heart failure or coronary artery disease;
- blood pressure monitors for individuals with hypertension;
- inhaled corticosteroids and peak flow meters for individuals with asthma;
- insulin and other glucose lowering agents, retinopathy screening, glucometers, and hemoglobin A1c testing for individuals with diabetes;
- international normalized ratio testing for individuals with liver disease or bleeding disorders;
- low-density lipoprotein testing for individuals with heart disease;
- statins for individuals with heart disease or diabetes; and
- selective serotonin reuptake inhibitors for individuals with depression.
The bill provides statutory authority for the IRS's guidance.


